Oncology

Restoring tumor suppressor genes

Our technologies can be applied to the development of new genetic medicines that can help to treat oncological targets.

We have the potential to restore specific genes that are involved in oncology. In many cancer forms tumor suppressors (e.g. TP53) have become ineffective. Our technology can be used to restore tumor suppressor functionality and could be used in combination with other cancer treatments to further enhance the combined effectiveness.

 

We use cookies to personalize our service and to improve your experience on the website. We also use thus information for analytics.